CN120981855A - 信息处理装置、信息处理方法及程序 - Google Patents
信息处理装置、信息处理方法及程序Info
- Publication number
- CN120981855A CN120981855A CN202480023446.8A CN202480023446A CN120981855A CN 120981855 A CN120981855 A CN 120981855A CN 202480023446 A CN202480023446 A CN 202480023446A CN 120981855 A CN120981855 A CN 120981855A
- Authority
- CN
- China
- Prior art keywords
- determination
- metabolic
- compound
- toxicity
- image
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
- G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
- G16C20/30—Prediction of properties of chemical compounds, compositions or mixtures
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B45/00—ICT specially adapted for bioinformatics-related data visualisation, e.g. displaying of maps or networks
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
- G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
- G16C20/80—Data visualisation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
- G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
- G16C20/10—Analysis or design of chemical reactions, syntheses or processes
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Theoretical Computer Science (AREA)
- Bioinformatics & Computational Biology (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Data Mining & Analysis (AREA)
- Crystallography & Structural Chemistry (AREA)
- Computing Systems (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Evolutionary Biology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medical Informatics (AREA)
- Cell Biology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023-059423 | 2023-03-31 | ||
| JP2023059423 | 2023-03-31 | ||
| PCT/JP2024/001437 WO2024202432A1 (ja) | 2023-03-31 | 2024-01-19 | 情報処理装置、情報処理方法、及びプログラム |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN120981855A true CN120981855A (zh) | 2025-11-18 |
Family
ID=92904979
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202480023446.8A Pending CN120981855A (zh) | 2023-03-31 | 2024-01-19 | 信息处理装置、信息处理方法及程序 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20260029395A1 (https=) |
| EP (1) | EP4693304A1 (https=) |
| JP (1) | JPWO2024202432A1 (https=) |
| CN (1) | CN120981855A (https=) |
| WO (1) | WO2024202432A1 (https=) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004093234A (ja) | 2002-08-30 | 2004-03-25 | Hitachi Ltd | 毒性有無判定方法 |
| WO2011055820A1 (ja) | 2009-11-09 | 2011-05-12 | 大日本住友製薬株式会社 | 支援装置、支援方法、及びコンピュータプログラム |
| US8703424B2 (en) | 2010-03-22 | 2014-04-22 | Stemina Biomarker Discovery, Inc. | Predicting human developmental toxicity of pharmaceuticals using human stem-like cells and metabolomics |
| JP7059220B2 (ja) * | 2019-02-15 | 2022-04-25 | 株式会社日立製作所 | 機械学習プログラム検証装置および機械学習プログラム検証方法 |
| JP2023059423A (ja) | 2021-10-15 | 2023-04-27 | 株式会社アイシン | 回転電機用固定子 |
-
2024
- 2024-01-19 CN CN202480023446.8A patent/CN120981855A/zh active Pending
- 2024-01-19 WO PCT/JP2024/001437 patent/WO2024202432A1/ja not_active Ceased
- 2024-01-19 EP EP24778578.5A patent/EP4693304A1/en active Pending
- 2024-01-19 JP JP2025509790A patent/JPWO2024202432A1/ja active Pending
-
2025
- 2025-09-26 US US19/341,755 patent/US20260029395A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JPWO2024202432A1 (https=) | 2024-10-03 |
| EP4693304A1 (en) | 2026-02-11 |
| WO2024202432A1 (ja) | 2024-10-03 |
| US20260029395A1 (en) | 2026-01-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Henderson et al. | Individualized treatment effects with censored data via fully nonparametric Bayesian accelerated failure time models | |
| Ganna et al. | Risk prediction measures for case-cohort and nested case-control designs: an application to cardiovascular disease | |
| Buck Louis et al. | The exposome research paradigm: an opportunity to understand the environmental basis for human health and disease | |
| Zhang et al. | Differential dependency network analysis to identify condition-specific topological changes in biological networks | |
| Goldsmith et al. | Corrected confidence bands for functional data using principal components | |
| US20170011169A1 (en) | Integrative pathway modeling for drug efficacy prediction | |
| Scheel et al. | The influence of missing value imputation on detection of differentially expressed genes from microarray data | |
| EP2600269A2 (en) | Microarray sampling and network modeling for drug toxicity prediction | |
| Basu et al. | Bayesian analysis of competing risks with partially masked cause of failure | |
| Comess et al. | A Bayesian framework for incorporating exposure uncertainty into health analyses with application to air pollution and stillbirth | |
| Botos et al. | Prenatal and postnatal genetic testing toward personalized care: the non-invasive perinatal testing | |
| Guo et al. | Generation of realistic virtual adult populations using a model-based copula approach | |
| Li et al. | Assessing quantile prediction with censored quantile regression models | |
| Farrell et al. | Online direct-to-consumer messages about non-invasive prenatal genetic testing | |
| CN120981855A (zh) | 信息处理装置、信息处理方法及程序 | |
| Kedron et al. | A Replication of DiMaggio et al.(2020) in Phoenix, AZ | |
| CA3287878A1 (en) | Information processing apparatus, information processing method, and program | |
| EP4693303A1 (en) | Information processing device, information processing method, and program | |
| Cheng et al. | Nonparametric association analysis of exchangeable clustered competing risks data | |
| Samawi et al. | Medical diagnostics accuracy measures and cut-point selection: an innovative approach based on relative net benefit | |
| US20260094323A1 (en) | Information processing apparatus, information processing method, and program | |
| EP4693305A1 (en) | Information processing device, information processing method, and program | |
| CN112581250B (zh) | 模型生成方法、装置、计算机设备和存储介质 | |
| EP4693311A1 (en) | Information processing device, information processing method, and program | |
| Jeong et al. | Application of smoothing methods to evaluate treatment-prognostic factor interactions in breast cancer data |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |